Sex differences in δ9-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent rats

Neuroscience Letters

Volumn 576, Issue , 2014, Pages 51-55

  Wiley, Jenny L ^a   Burston, James J ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adolescence; Cannabinoids; Delta 9 tetrahydrocannabinol; Metabolism; Sex differences; Tolerance

Indexed keywords

DRONABINOL; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BRAIN LEVEL; CATALEPSY; DRUG METABOLISM; FEMALE; HYPOTHERMIA; IN VIVO STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; SEX DIFFERENCE; TREATMENT DURATION; AGE; ANIMAL; BRAIN; DOSE RESPONSE; DRUG EFFECTS; LONG EVANS RAT; METABOLISM; MOTOR ACTIVITY;

AGE FACTORS; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRONABINOL; FEMALE; MALE; MOTOR ACTIVITY; PSYCHOTROPIC DRUGS; RATS, LONG-EVANS; SEX FACTORS;

EID: 84902577055     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.05.057     Document Type: Article

References (23)

1. Johnston L.D., O'Malley P.M., Miech R.A., Bachman J.G., Schulenberg J.E. Monitoring the Future National Results on Drug Use: 1975-2013: Overview, Key Findings on Adolescent Drug Use 2014, Institute for Social Research, The University of Michigan, Ann Arbor.
2. Battistella G., Fornari E., Annoni J.M., Chtioui H., Dao K., Fabritius M., Favrat B., Mall J.F., Maeder P., Giroud C. Long-term effects of cannabis on brain structure. Neuropsychopharmacology 2014, Epub ahead of print. 10.1038/npp.2014.67.
3. Brook J.S., Stimmel M.A., Zhang C., Brook D.W. The association between earlier marijuana use and subsequent academic achievement and health problems: a longitudinal study. Am. J. Addict. 2008, 17:155-160.
4. Chang L., Yakupov R., Cloak C., Ernst T. Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain 2006, 129:1096-1112.
5. Ehrenreich H., Rinn T., Kunert H.J., Moeller M.R., Poser W., Schilling L., Gigerenzer G., Hoehe M.R. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl) 1999, 142:295-301.
6. Jacobus J., Bava S., Cohen-Zion M., Mahmood O., Tapert S.T. Functional consequences of marijuana use in adolescents. Pharmacol. Biochem. Behav. 2009, 92:559-565.
7. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24:417-463.
8. Quinn H.R., Matsumoto I., Callaghan P.D., Long L.E., Arnold J.C., Gunasekaran N., Thompson M.R., Dawson B., Mallet P.E., Kashem M.A., Matsuda-Matsumoto H., Iwazaki T., McGregor I.S. Adolescent rats find repeated delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology 2008, 33:1113-1126.
9. Rubino T., Vigano D., Realini N., Guidali C., Braida D., Capurro V., Castiglioni C., Cherubino F., Romualdi P., Candeletti S., Sala M., Parolaro D. Chronic delta(9)-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 2008, 33:2760-2771.
10. Schneider M., Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 2003, 28:1760-1769.
11. Wiley J.L., O'Connell M.M., Tokarz M.E., Wright M.J. Pharmacological effects of acute and repeated administration of delta(9)-tetrahydrocannabinol in adolescent and adult rats. J. Pharmacol. Exp. Ther. 2007, 320:1097-1105.
12. Craft R.M., Marusich J.A., Wiley J.L. Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system. Life Sci. 2013, 92:476-481.
13. 9-tetrahydrocannabinol in the rat. Biochem. Pharmacol. 1991, 41:1187-1194.
14. 9-tetrahydrocannabinol-induced behavioral effects in rats. Behav. Brain Res. 2004, 154:77-83.
15. Foltz R.L., McGinnis K.M., Chinn D.M. Quantitative measurement of delta 9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry. Biomed. Mass Spectrom. 1983, 10:316-323.
16. 9-tetrahydrocannabinol-induced motor effects in female rats. Neuropharmacology 2011, 60:274-283.
17. 1-tetrahydrocannabinol and other cannabinoids with an emphasis on man. Pharmacol. Rev. 1986, 38:21-43.
18. 9-tetrahydrocannabinol by rat liver microsomes. Drug Metab. Dispos. 1990, 18:943-948.
19. Narimatsu S., Watanabe K., Matsunaga T., Yamamoto I., Imaoka S., Funae Y., Yoshimura H. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta-9-tetrahydrocannabinol by liver microsomes of adult female rats. Drug Metab. Dispos. 1992, 20:79-83.
20. Browne R.G., Weissman A. Discriminative stimulus properties of delta 9-tetrahydrocannabinol: mechanistic studies. J. Clin. Pharmacol. 1981, 21:227S-234S.
21. Tseng A.H., Craft R.M. Sex differences in antinociceptive and motoric effects of cannabinoids. Eur. J. Pharmacol. 2001, 430:41-47.
22. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., Johnson M.R., Melvin L.S., Mechoulam R., Ward S.J. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 1991, 40:471-478.
23. Barrett A.C., Cook C.D., Terner J.M., Craft R.M., Picker M.J. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids. Psychopharmacology (Berl) 2001, 158:154-164.